The authors reply

doi:10.1016/j.kint.2025.03.005

2025-05-20

PRE

Smeeta Sinha

Rachel M. Holden

Rosa Maria Affonso Moysés

M. Ketteler

DOI：10.1016/j.kint.2025.03.005

原文链接

原文求助

摘要

期刊

Kidney International

IF:

12.6

论文数:

1.6W

被引数:

4.8W

机构

暂无机构信息

引用论文

Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis 肾移植和高压氧治疗用于钙化防御

Kidney International

IF12.6

2025-05-20

PREAI

Espen Nordheim; Markus Hovd; Dag Olav Dahle

Adaptive Designs for Clinical Trials in Nephrology

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF9.4

2024-08-26

PREAI

Krishnasamy, Rathika; Jardine, Meg J.

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension 六磷酸六钠用于治疗钙化防御: 一项随机，双盲，3期，安慰剂对照试验，具有开放标签扩展

ECLINICALMEDICINE

IF10

2024-09-01

OAAI

Sinha, Smeeta; Nigwekar, Sagar U.; Brandenburg, Vincent; Gould, Lisa J.; Serena, Thomas E.; Moe, Sharon M.; Aronoff, George R.; Chatoth, Dinesh K.; Hymes, Jeffrey L.; Carroll, Kevin J.; Alperovich, Gabriela; Keller, Laurence H.; Perello, Joan; Gold, Alex; Chertow, Glenn M.